Series A · Biotech
IMU Biosciences: Series A
Profiles the human immune system at scale using multi-omic analysis and machine learning to transform disease diagnosis and treatment
Funding history
Series A · This round$53M
Loading rounds…
Profiles the human immune system at scale using multi-omic analysis and machine learning to transform disease diagnosis and treatment